SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-028563
Filing Date
2023-08-09
Accepted
2023-08-09 16:06:41
Documents
16
Period of Report
2023-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf-20230808.htm   iXBRL 8-K 35615
2 EX-3.1 a31ex080823.htm EX-3.1 14238
3 EX-99.1 crdf063023-q22023pr.htm EX-99.1 106626
7 crdf-20230808_g1.jpg GRAPHIC 2732
8 image_0.jpg GRAPHIC 7491
  Complete submission text file 0001628280-23-028563.txt   314345

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20230808.xsd EX-101.SCH 1925
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20230808_lab.xml EX-101.LAB 23878
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20230808_pre.xml EX-101.PRE 12536
10 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20230808_htm.xml XML 2707
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 231155134
SIC: 2836 Biological Products, (No Diagnostic Substances)